Here are five quick facts on the company’s financial report:
1. Full-year 2014 revenue was reported at $118.2 million, which is up 100 percent over the same period last year.
2. Fourth quarter revenue hit $39.6 million, which is 120 percent higher than the same period in 2013.
3. The fourth quarter marked the 13th consecutive quarter the company met or exceeded revenue guidance.
4. The wound care revenue is growing quickly and the company is advancing toward capturing market share.
5. Last year, the company expanded efforts in the surgical sector, and MiMedx hopes to build moment through the end of this year.
6. In 2015, the company expects revenue to reach $175 million to $190 million, which was higher than earlier expectations.
More articles on orthopedic devices:
Globus Medical, Medtronic, Mazor Robotics & more—10 key notes
Inside orthopedic, spine device companies—3 stock trends
Benvenue Medical names Rick Simmons VP of sales & marketing
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
